Is retatrutide FDA approved?
No, it is still experimental. Its large final-stage study, TRIUMPH-1, included 2,339 people and reported results in May 2026. The company was expected to ask for approval later in 2026. Until the FDA reviews and approves it, retatrutide is not a legal prescription drug anywhere. That is why every seller offering it is selling an unapproved research chemical, not a medicine.
Every FDA-approved compound in the archive, as a list
Studies in people from the compound pages this answer belongs to
- Retatrutide
- Triple-Hormone-Receptor Agonist Retatrutide for Obesity: A Phase 2 Trial 2023 PMID 37366315
- Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial 2024 PMID 38858523
- A Master Protocol to Investigate the Efficacy and Safety of LY3437943 Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Overweight (TRIUMPH-1) 2026 NCT05929066
Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.
Part of glp-1 and metabolic peptides. Semaglutide, tirzepatide, retatrutide, and the rest of the incretin and glucagon receptor family.